Abstract:Lung cancer (LC) is the leading cause of cancer deaths worldwide, being non-small lung cancer (NSCLC) sub-types the most prevalent. Since most LC cases are only detected during the last stage of the disease the high mortality rate is strongly associated with metastases. For this reason, the migratory and invasive capacity of these cancer cells as well as the mechanisms involved have long been studied to uncover novel strategies to prevent metastases and improve the patients' prognosis. This narrative review provides an overview of the main in vitro migration and invasion assays employed in NSCLC research. While several methods have been developed, experiments using conventional cell culture models prevailed, specifically the wound-healing and the transwell migration and invasion assays. Moreover, it is provided herewith a summary of the available information concerning chemical contaminants that may promote the migratory/invasive properties of NSCLC cells in vitro, shedding some light on possible LC risk factors. Most of the reported agents with pro-migration/invasion effects derive from cigarette smoking [e.g., Benzo(a)pyrene and cadmium] and air pollution. This review further presents several studies in which different dietary/plant-derived compounds demonstrated to impair migration/invasion processes in NSCLC cells in vitro. These chemicals that have been proposed as anti-migratory consisted mainly of natural bioactive substances, including polyphenols non-flavonoids, flavonoids, bibenzyls, terpenes, alkaloids, and steroids. Some of these compounds may eventually represent novel therapeutic strategies to be considered in the future to prevent metastasis formation in LC, which highlights the need for additional in vitro methodologies that more closely resemble the in vivo tumor microenvironment and cancer cell interactions. These studies along with adequate in vivo models should be further explored as proof of concept for the most promising compounds.

Recently reported cell migration inhibitors: Opportunities and challenges for antimetastatic agents

Current methods for studying metastatic potential of tumor cells

Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives

Progress and Challenge in Development of Biotherapeutics Targeting MET Receptor for Treatment of Advanced Cancer.

Plasticity of cancer cell invasion: Patterns and mechanisms

Cancer metastases: challenges and opportunities

Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives

Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review

Anti-metastatic drug development, overview and perspectives

A narrative review of the migration and invasion features of non-small cell lung cancer cells upon xenobiotic exposure: insights from in vitro studies

Targeting metastatic cancer

Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target

Molecular Insights into Tumour Metastasis: Tracing the Dominant Events

In vitro wound healing of tumor cells: inhibition of cell migration by selected cytotoxic alkaloids

Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy

Cell adhesion and migration in disease: translational and therapeutic opportunities

Tumor cell migration in complex microenvironments

A More Biomimetic Cell Migration Assay with High Reliability and Its Applications

Development of Individualized Anti-Metastasis Strategies by Engineering Nanomedicines.

Recent Advances in Discovering the Role of Ccl5 in Metastatic Breast Cancer

How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers